214 related articles for article (PubMed ID: 35437719)
1. Applications of Quantitative System Pharmacology Modeling to Model-Informed Drug Development.
Zhu AZX; Rogge M
Methods Mol Biol; 2022; 2486():71-86. PubMed ID: 35437719
[TBL] [Abstract][Full Text] [Related]
2. Review of applications and challenges of quantitative systems pharmacology modeling and machine learning for heart failure.
Cheng L; Qiu Y; Schmidt BJ; Wei GW
J Pharmacokinet Pharmacodyn; 2022 Feb; 49(1):39-50. PubMed ID: 34637069
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Systems Pharmacology for Rare Disease Drug Development.
Bai JP; Wang J; Zhang Y; Wang L; Jiang X
J Pharm Sci; 2023 Sep; 112(9):2313-2320. PubMed ID: 37422281
[TBL] [Abstract][Full Text] [Related]
4. Physiological Indirect Response Model to Omics-Powered Quantitative Systems Pharmacology Model.
Uatay A; Gall L; Irons L; Tewari SG; Zhu XS; Gibbs M; Kimko H
J Pharm Sci; 2024 Jan; 113(1):11-21. PubMed ID: 37898164
[TBL] [Abstract][Full Text] [Related]
5. Translational Quantitative Systems Pharmacology in Drug Development: from Current Landscape to Good Practices.
Bai JPF; Earp JC; Pillai VC
AAPS J; 2019 Jun; 21(4):72. PubMed ID: 31161268
[TBL] [Abstract][Full Text] [Related]
6. FDA-Industry Scientific Exchange on assessing quantitative systems pharmacology models in clinical drug development: a meeting report, summary of challenges/gaps, and future perspective.
Bai JPF; Schmidt BJ; Gadkar KG; Damian V; Earp JC; Friedrich C; van der Graaf PH; Madabushi R; Musante CJ; Naik K; Rogge M; Zhu H
AAPS J; 2021 Apr; 23(3):60. PubMed ID: 33931790
[TBL] [Abstract][Full Text] [Related]
7. Recent applications of quantitative systems pharmacology and machine learning models across diseases.
Aghamiri SS; Amin R; Helikar T
J Pharmacokinet Pharmacodyn; 2022 Feb; 49(1):19-37. PubMed ID: 34671863
[TBL] [Abstract][Full Text] [Related]
8. [An introduction to QSP modeling for pharmacologists].
Sayama H; Nagasaka Y; Tabata K
Nihon Yakurigaku Zasshi; 2019; 154(3):143-150. PubMed ID: 31527365
[TBL] [Abstract][Full Text] [Related]
9. Quantitative system pharmacology as a legitimate approach to examine extrapolation strategies used to support pediatric drug development.
Azer K; Barrett JS
CPT Pharmacometrics Syst Pharmacol; 2022 Jul; 11(7):797-804. PubMed ID: 35411657
[TBL] [Abstract][Full Text] [Related]
10. From Cold to Hot: Changing Perceptions and Future Opportunities for Quantitative Systems Pharmacology Modeling in Cancer Immunotherapy.
Lemaire V; Bassen D; Reed M; Song R; Khalili S; Lien YTK; Huang L; Singh AP; Stamatelos S; Bottino D; Hua F
Clin Pharmacol Ther; 2023 May; 113(5):963-972. PubMed ID: 36282521
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Systems Pharmacology: An Exemplar Model-Building Workflow With Applications in Cardiovascular, Metabolic, and Oncology Drug Development.
Helmlinger G; Sokolov V; Peskov K; Hallow KM; Kosinsky Y; Voronova V; Chu L; Yakovleva T; Azarov I; Kaschek D; Dolgun A; Schmidt H; Boulton DW; Penland RC
CPT Pharmacometrics Syst Pharmacol; 2019 Jun; 8(6):380-395. PubMed ID: 31087533
[TBL] [Abstract][Full Text] [Related]
12. A framework for simplification of quantitative systems pharmacology models in clinical pharmacology.
Derbalah A; Al-Sallami H; Hasegawa C; Gulati A; Duffull SB
Br J Clin Pharmacol; 2022 Feb; 88(4):1430-1440. PubMed ID: 32621550
[TBL] [Abstract][Full Text] [Related]
13. Quantitative systems pharmacology: Landscape analysis of regulatory submissions to the US Food and Drug Administration.
Bai JPF; Earp JC; Florian J; Madabushi R; Strauss DG; Wang Y; Zhu H
CPT Pharmacometrics Syst Pharmacol; 2021 Dec; 10(12):1479-1484. PubMed ID: 34734497
[TBL] [Abstract][Full Text] [Related]
14. Applications of Quantitative Systems Pharmacology (QSP) in Drug Development for NAFLD and NASH and Its Regulatory Application.
Siler SQ
Pharm Res; 2022 Aug; 39(8):1789-1802. PubMed ID: 35610402
[TBL] [Abstract][Full Text] [Related]
15. Virtual Populations for Quantitative Systems Pharmacology Models.
Cheng Y; Straube R; Alnaif AE; Huang L; Leil TA; Schmidt BJ
Methods Mol Biol; 2022; 2486():129-179. PubMed ID: 35437722
[TBL] [Abstract][Full Text] [Related]
16. QSP-IO: A Quantitative Systems Pharmacology Toolbox for Mechanistic Multiscale Modeling for Immuno-Oncology Applications.
Sové RJ; Jafarnejad M; Zhao C; Wang H; Ma H; Popel AS
CPT Pharmacometrics Syst Pharmacol; 2020 Sep; 9(9):484-497. PubMed ID: 32618119
[TBL] [Abstract][Full Text] [Related]
17. Practical QSP application from the preclinical phase to enhance the probability of clinical success: Insights from case studies in oncology.
Oishi M; Sayama H; Toshimoto K; Nakayama T; Nagasaka Y
Drug Metab Pharmacokinet; 2024 Jun; 56():101020. PubMed ID: 38797089
[TBL] [Abstract][Full Text] [Related]
18. The convergence of pharmacometrics and quantitative systems pharmacology in pharmaceutical research and development.
Joshi A; Ramanujan S; Jin JY
Eur J Pharm Sci; 2023 Mar; 182():106380. PubMed ID: 36638898
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Systems Pharmacology for Neuroscience Drug Discovery and Development: Current Status, Opportunities, and Challenges.
Geerts H; Wikswo J; van der Graaf PH; Bai JPF; Gaiteri C; Bennett D; Swalley SE; Schuck E; Kaddurah-Daouk R; Tsaioun K; Pelleymounter M
CPT Pharmacometrics Syst Pharmacol; 2020 Jan; 9(1):5-20. PubMed ID: 31674729
[TBL] [Abstract][Full Text] [Related]
20. Two heads are better than one: current landscape of integrating QSP and machine learning : An ISoP QSP SIG white paper by the working group on the integration of quantitative systems pharmacology and machine learning.
Zhang T; Androulakis IP; Bonate P; Cheng L; Helikar T; Parikh J; Rackauckas C; Subramanian K; Cho CR;
J Pharmacokinet Pharmacodyn; 2022 Feb; 49(1):5-18. PubMed ID: 35103884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
